AQR Capital Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $146K | Sell |
11,218
-849
| -7% | -$11K | ﹤0.01% | 3115 |
|
|
2025
Q1 | $128K | Buy |
+12,067
| New | +$128K | ﹤0.01% | 2970 |
|
|
2024
Q4 | – | Sell |
-12,078
| Closed | -$280K | – | 2870 |
|
|
2024
Q3 | $280K | Buy |
12,078
+378
| +3% | +$8.77K | ﹤0.01% | 2423 |
|
|
2024
Q2 | $285K | Sell |
11,700
-62,525
| -84% | -$1.52M | ﹤0.01% | 2289 |
|
|
2024
Q1 | $2.51M | Sell |
74,225
-85,648
| -54% | -$2.89M | ﹤0.01% | 1309 |
|
|
2023
Q4 | $5.04M | Sell |
159,873
-12,329
| -7% | -$389K | 0.01% | 947 |
|
|
2023
Q3 | $4.4M | Buy |
172,202
+121,526
| +240% | +$3.1M | 0.01% | 978 |
|
|
2023
Q2 | $1.45M | Buy |
+50,676
| New | +$1.45M | ﹤0.01% | 1401 |
|
|
2021
Q1 | – | Sell |
-11,914
| Closed | -$517K | – | 2189 |
|
|
2020
Q4 | $517K | Sell |
11,914
-4,842
| -29% | -$210K | ﹤0.01% | 1765 |
|
|
2020
Q3 | $719K | Buy |
+16,756
| New | +$719K | ﹤0.01% | 1569 |
|